Asterand Introduces Nine Ways to Accelerate Cancer Research
Posted on: Wednesday, 19 October 2005, 12:00 CDT
DETROIT, Oct. 19 /PRNewswire/ -- Asterand, Inc., the Detroit-based supplier of human tissues and related services, announces the distribution of nine cell lines for cancer research. The cell lines were all developed at the Barbara Ann Karmanos Cancer Institute of Wayne State University and will be of interest to researchers seeking a cure for lymphoma, leukemia, pancreatic cancer, and macroglobulinema.
"These cell lines are very good model systems for diseases that they are derived from," says Dr James Eliason, the chief scientific officer of Asterand. "They have been studied extensively by researchers at Wayne State University and elsewhere, which is evident by the fact that there are over 50 publications related to them. The data reported in these published papers have led to at least one clinical trial.
"In addition to common cancers, these cell lines are great resources for studying rare cancers such as Burkitt's lymphoma, which affects children and young people, aged 12-30, or pancreatic cancer, which is probably one of the most difficult cancers to detect."
Lymphoma will be responsible for an estimated 21,000 deaths and leukemia an estimated 22,000 deaths in the United States this year according to the American Cancer Society.
The Wayne State lines will be added to a portfolio of cell lines that are currently distributed by Asterand. The company markets breast cancer cell lines under license from the University of Michigan and prostate cancer lines from the English biotechnology company Onyvax.
"We have a close working relationship with Wayne State University which we value highly," says Asterand CEO Randal Charlton. "We have an important joint tissue based research project with the university and under another collaborative agreement, Wayne State University researchers have preferred access to the extensive Asterand tissue bank which currently contains over 330,000 samples."
The WSU cell lines will be available worldwide for both commercial and academic researchers.
About the Wayne State Cell lines
The cell lines were developed by Drs. Ayad Al-Katib and Ramzi Mohammad. The complete list is as follows:
1. WSU-WM Waldenstrom's macroglobulinema 2. WSU-FSCCL Follicular small cleaved cell lymphoma 3. WSU-DLCL2 Diffuse large cell lymphoma, chemo-resistant 4. WSU-preAll Acute lymphoblastic leukemia, early stage 5. WSU-AML Acute myeloid leukemia 6. WSU-MOH1 Pancreatic cancer 7. WSU-DLCL Diffuse large cell lymphoma 8. WSU-BL Burkitt's lymphoma 9. WSU-NHL Nodal histiocytic lymphoma, intermediate grade About Asterand
Asterand is the leading provider of human tissue for genomic and proteomic research. The company acquires donated samples from a world wide network of collaborating hospitals and clinics. These samples together with associated data and pathology reports are made available to commercial drug discovery companies as well as researchers at academic institutions.
Asterand supplies tissues in a variety of formats including fresh, frozen and fixed as well as derivative products such as tissue microarrays, RNA and DNA. The company also carries out a wide range of applied research projects on behalf of clients.
For more information, contact Dr. James Eliason or Randal Charlton at 313-263-0960 or visit Asterand's website at http://www.asterand.com/ .
About Wayne State University
Wayne State University (WSU) is a premier institution of higher education offering more than 350 academic programs through 12 schools and colleges to more than 33,000 students. With more than 1,000 medical students, WSU has one of the nation's largest medical schools. Together with its clinical partner the Detroit Medical Center, the school is a leader in patient care and medical research in a number of areas, including cancer, genetics, the neurosciences and women's and children's health.
Asterand, Inc.
CONTACT: Dr. James Eliason or Randal Charlton of Asterand, Inc.,+1-313-263-0960
Web site: http://www.asterand.com/
Source: PRNewswire
Related Articles
- Gene Regulates Cancer Stem Cells in Brain Cancer
- Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
- University Researcher Seeks Better Flour
- Mississippi State University Research May Lead To New Treatments for Bacterial Infections
- PhytoMedical and Iowa State University Research Foundation Announce a License Agreement for Novel Synthesized Compounds
- Researchers Use Human Embryonic Stem Cells to Kill Cancer Cells
- Chinese Anti-Cancer Vaccine Approved for Clinical Research
- Fat Cells Fight Disease, Purdue University Researchers Find
- Antiproton Radiation Found Biologically Effective in Terminating Cells Used in Cancer Research
- Knapweed Taints Soil, Colorado State University Researchers Report
 |
 |
User Comments (0)
RSS Feeds